Show simple item record

dc.contributor.authorPaz-Ares, L.
dc.contributor.authorConev, N.
dc.contributor.authorBar, J.
dc.contributor.authorBroadhurst, H.
dc.contributor.authorByrne, N.
dc.contributor.authorJiang, H.
dc.contributor.authorReinmuth, N.
dc.contributor.authorGarassino, M. C.
dc.contributor.authorTrukhin, D.
dc.contributor.authorHochmair, M. J.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorHavel, L.
dc.contributor.authorGoldman, J.
dc.contributor.authorChen, Y.
dc.contributor.authorLosonczy, G.
dc.contributor.authorSpinnato, F.
dc.date.accessioned2021-12-10T12:17:12Z
dc.date.available2021-12-10T12:17:12Z
dc.date.issued2021
dc.identifier.citationReinmuth N., Garassino M. C. , Trukhin D., Hochmair M. J. , Ozguroglu M., Havel L., Goldman J., Chen Y., Losonczy G., Spinnato F., et al., "First-Line Durvalumab plus Platinum-Etoposide in ES-SCLC: Exploratory Analyses Based on Extent of Disease in CASPIAN", JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.3, 2021
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_b2fd6a4d-5b91-482b-b34e-f78f77559c8f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173590
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectRespiratory Care
dc.subjectPulmonary and Respiratory Medicine
dc.subjectHealth Sciences
dc.subjectKlinik Tıp
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp (MED)
dc.titleFirst-Line Durvalumab plus Platinum-Etoposide in ES-SCLC: Exploratory Analyses Based on Extent of Disease in CASPIAN
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentAsklepios Lung Clin , ,
dc.identifier.volume16
dc.identifier.issue3
dc.contributor.firstauthorID2622012


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record